PMID: 11920455Mar 29, 2002Paper

Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma. Changes in management and determinants of where care is delivered

Cancer
Jennifer ClausonMonica Morrow

Abstract

The treatment options of breast conservation therapy (BCT) and immediate reconstruction for patients with carcinoma of the breast have not been adopted widely. The objectives of this study were to determine how often a second opinion on the local therapy of breast carcinoma changed patient management and to identify factors predictive of remaining at the second-opinion site for therapy. Two hundred thirty-one patients with intraductal carcinoma or Stage I and II breast carcinoma were reviewed retrospectively. At the time of the second opinion, patients completed a questionnaire regarding their initial surgical opinion and the reason for seeking consultation. Only 46% of patients had a complete discussion of treatment options prior to the second opinion. The second opinion changed management in 54 patients (20.3%). The most common finding was eligibility for BCT in patients who were offered only mastectomy. Definitive local therapy occurred at the second-opinion site in 65.8% of patients. The only predictors of remaining at the second-opinion site were insurance type (P = 0.008) and the patient's perception that options were not discussed at the initial opinion (P < 0.001). Second opinions provide useful information to patients ...Continue Reading

References

Apr 1, 1979·Medical Care·C A WattsJ P LoGerfo
May 1, 1992·CA: a Cancer Journal for Clinicians·D P Winchester, J D Cox
Sep 1, 1990·Medical Care·M L Finkel, D J Finkel
Jun 1, 1989·Journal of Clinical Gastroenterology·L R Sutherland, M J Verhoef
Sep 25, 1987·JAMA : the Journal of the American Medical Association·T B GraboysC M Blatt
Jan 1, 1982·Medical Care·S G MartinA E McKusick
Oct 1, 1994·Journal of Clinical Gastroenterology·L R Sutherland, M J Verhoef
Dec 1, 1994·American Journal of Surgery·R L PaulsonS D Helmer
Nov 14, 1997·Journal of the American College of Surgeons·C K McSherryE G McCarthy
Mar 24, 1998·Journal of the American College of Surgeons·M MorrowA Rademaker
Sep 2, 1999·Journal of the National Cancer Institute·M HewittS Devesa
Sep 25, 1999·Health Affairs·T H Wagner, L S Wagner
Feb 24, 2001·Journal of the American College of Surgeons·M MorrowD P Winchester
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MorrowD Winchester

❮ Previous
Next ❯

Citations

Sep 7, 2002·Cancer·Valerie L StaradubMonica Morrow
Oct 24, 2002·The New England Journal of Medicine·Monica Morrow
Feb 22, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Martin A MartinoMitchel S Hoffman
Jun 14, 2003·BMJ : British Medical Journal·Alejandro R JadadMurray W Enkin
May 19, 2007·Annals of Surgical Oncology·Diane OpattSteven J Katz
Dec 30, 2009·Annals of Surgical Oncology·Bernard T LeeAdam M Tobias
Nov 19, 2015·Radiology·Robert J GilliesHedvig Hricak
Feb 27, 2003·The Breast Journal·Shahla Masood
Sep 23, 2003·Journal of Surgical Oncology·Monica Morrow
Feb 16, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Sawako OkamotoYujiro Tanaka
Jul 31, 2007·Journal of the American College of Surgeons·UNKNOWN American College of Radiology
Dec 17, 2014·Psycho-oncology·Flora TzelepisTara Clinton-McHarg
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna GagliardiWilliam K Evans
Dec 10, 2017·Israel Journal of Health Policy Research·Liora ShmueliGeva Greenfield
Dec 22, 2015·Journal of Cancer Research and Clinical Oncology·Dana RuettersJutta Huebner
Jun 14, 2017·The Oncologist·Marij A HillenEllen M A Smets
Feb 29, 2020·Diseases of the Colon and Rectum·Ana C De RooSamantha Hendren
Jul 10, 2020·PloS One·Pascal M BurgerBram E L Vrijsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Francisco Javier González-BarcalaLuis Valdés-Cuadrado
© 2022 Meta ULC. All rights reserved